Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Celergen is a Swiss nutraceutical company that specializes in anti-aging and regenerative wellness through marine-based cell therapy supplements. Its flagship product, also named Celergen, is an oral softgel formulated with a proprietary Bio-DNA Cellular Marine Complex, Peptide E Collagen, and Hydro MN Peptide. The company markets its products as a non-invasive alternative to traditional injectable cell therapy, aiming to enhance energy levels, improve joint health, and promote skin rejuvenation. Celergen's manufacturing processes utilize cold extraction technology to maintain the biological activity of its marine-derived ingredients. The company targets the global luxury health market, positioning itself at the intersection of biotechnology and nutritional science.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Celergén.